These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1944243)

  • 1. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.
    Wall SJ; Yasuda RP; Li M; Wolfe BB
    Mol Pharmacol; 1991 Nov; 40(5):783-9. PubMed ID: 1944243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
    Yasuda RP; Ciesla W; Flores LR; Wall SJ; Li M; Satkus SA; Weisstein JS; Spagnola BV; Wolfe BB
    Mol Pharmacol; 1993 Feb; 43(2):149-57. PubMed ID: 8429821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.
    Wall SJ; Yasuda RP; Hory F; Flagg S; Martin BM; Ginns EI; Wolfe BB
    Mol Pharmacol; 1991 May; 39(5):643-9. PubMed ID: 2034236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
    Li M; Yasuda RP; Wall SJ; Wellstein A; Wolfe BB
    Mol Pharmacol; 1991 Jul; 40(1):28-35. PubMed ID: 1857338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
    Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB
    Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of subtypes m1-m5 of muscarinic receptors in forebrain by chronic atropine administration.
    Wall SJ; Yasuda RP; Li M; Ciesla W; Wolfe BB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):584-8. PubMed ID: 1323653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
    Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man.
    Ryberg AT; Warfvinge G; Axelsson L; Soukup O; Götrick B; Tobin G
    Arch Oral Biol; 2008 Jan; 53(1):66-74. PubMed ID: 17825245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ; Bonner TI; Buckley CM; Brann MR
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type.
    Koenig JA; Edwardson JM
    Mol Pharmacol; 1996 Feb; 49(2):351-9. PubMed ID: 8632769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S; Buckley NJ; Roberts FF
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of mRNAs encoding muscarinic receptor subtypes in human detrusor muscle.
    Yamaguchi O; Shishido K; Tamura K; Ogawa T; Fujimura T; Ohtsuka M
    J Urol; 1996 Sep; 156(3):1208-13. PubMed ID: 8709348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of organophosphate exposure on muscarinic acetylcholine receptor subtype mRNA levels in the adult rat.
    Yagle K; Costa LG
    Neurotoxicology; 1996; 17(2):523-30. PubMed ID: 8856746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues.
    Dörje F; Levey AI; Brann MR
    Mol Pharmacol; 1991 Oct; 40(4):459-62. PubMed ID: 1921982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of muscarinic m3 and m4 receptor antibodies with pharmacological activities.
    Wang HY; Zeng SJ; Qiu PX
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):523-6. PubMed ID: 10437137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of muscarinic receptor subtype mRNA in the human ciliary muscle.
    Zhang X; Hernandez MR; Yang H; Erickson K
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1645-57. PubMed ID: 7541396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
    Ehlert FJ; Griffin MT; Glidden PF
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation.
    Gil DW; Krauss HA; Bogardus AM; WoldeMussie E
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1434-42. PubMed ID: 9191607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.